Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Study on determination of eight metal elements in Hainan arecanut leaf by flame atomic absorption spectrophotometry].

Guang pu xue yu guang pu fen xi = Guang pu·2009

Same author

Pseudonocardia endophytica sp. nov., isolated from the pharmaceutical plant Lobelia clavata.

International journal of systematic and evolutionary microbiology·2009

Same author

Highly selective biotransformation of ginsenoside Rb1 to Rd by the phytopathogenic fungus Cladosporium fulvum (syn. Fulvia fulva).

Journal of industrial microbiology & biotechnology·2009

Same author

Synthesis and resolution of planar-chiral ruthenium-palladium complexes with ECE' pincer ligands.

Chemistry (Weinheim an der Bergstrasse, Germany)·2009

Same author

Human DNA sequences: more variation and less race.

American journal of physical anthropology·2009

Same author

Determination of organophosphorus pesticides in underground water by SPE-GC-MS.

Journal of chromatographic science·2009

Same journal

Recent advances in antiviral drugs for Chikungunya virus (CHIKV): Targets, mechanisms, and development strategies.

Acta pharmaceutica Sinica. B·2026

Same journal

Organoids, organ-on-a-chip, and microtumors: Biomimetic 3D tumor models advancing drug development and precision medicine.

Acta pharmaceutica Sinica. B·2026

Same journal

Engineered extracellular vesicles for combinatorial cancer therapy and imaging.

Acta pharmaceutica Sinica. B·2026

Same journal

The mechanisms and strategies for Alzheimer's disease prevention: An update.

Acta pharmaceutica Sinica. B·2026

Same journal

Ginsenoside Rg1 alleviates post-ischemic stroke neuroinflammation by inhibiting CKLF1-mediated suppression of dead/dying neuron clearance.

Acta pharmaceutica Sinica. B·2026

Same journal

Smart responsive hydrogels combined with AI design for tumor therapy.

Acta pharmaceutica Sinica. B·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 17, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

Engineered bacteria assist CAR-cell immunotherapy

Tianyu Shao¹, Manman Xu¹, Jie Li¹

¹Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.

Acta Pharmaceutica Sinica. B

|May 15, 2025

Summary

No abstract available in PubMed .

Keywords:

Antigen recognition Cancer immunotherapy Challenge Chimeric antigen receptor immunotherapy Cytotoxicity effects Engineered bacteria Solid tumor Tumor microenvironment

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Related Experiment Videos

Last Updated: May 17, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019